Published • loading... • Updated
Azelastine Nasal Spray Reduces Risk of Sars-Cov-2 Infections
Summary by Deutsches Ärzteblatt
1 Articles
1 Articles
Munich — A nasal spray containing 0.1% azelastine may reduce the risk of SARS-CoV-2 infections. It may also be effective against other respiratory viruses, reported Thorsten Lehr from Saarland University in Homburg at this year's congress of the German Society of Pneumology and Respiratory Medicine in Munich (DGP)...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
